1. Home
  2. CLFD vs MNPR Comparison

CLFD vs MNPR Comparison

Compare CLFD & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearfield Inc.

CLFD

Clearfield Inc.

HOLD

Current Price

$26.40

Market Cap

447.2M

Sector

Utilities

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$54.97

Market Cap

403.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLFD
MNPR
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.2M
403.4M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
CLFD
MNPR
Price
$26.40
$54.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$43.50
$107.00
AVG Volume (30 Days)
95.8K
162.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
31.76
54.99
EPS
N/A
N/A
Revenue
$85,034,000.00
N/A
Revenue This Year
$11.64
N/A
Revenue Next Year
$22.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.51
N/A
52 Week Low
$23.76
$26.06
52 Week High
$46.76
$105.00

Technical Indicators

Market Signals
Indicator
CLFD
MNPR
Relative Strength Index (RSI) 35.19 45.55
Support Level $24.58 $50.92
Resistance Level $30.99 $62.49
Average True Range (ATR) 1.48 4.08
MACD -0.23 -0.07
Stochastic Oscillator 42.60 27.19

Price Performance

Historical Comparison
CLFD
MNPR

About CLFD Clearfield Inc.

Clearfield Inc designs, manufactures, and distributes fiber protection, fiber management, and fiber delivery solutions to enable rapid and cost-effective fiber-fed deployment throughout the broadband service provider space prominently across North America. Its 'fiber to anywhere' platform serves the requirements of Community Broadband customers, Multiple System Operators, Large Regional Service Providers, National Carriers, and International customers (including Europe, Canada, Mexico, and Caribbean Markets). Its product offerings include Accessories, Cassettes, Cable & Drop Assemblies, Frames & Panels, Microducts, Optical Components, etc. The company derives the majority of its revenue from the United States.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: